_id
6919e8733c536f8df2318254
Ticker
GENF.LSE
Name
Genflow Biosciences plc
Exchange
LSE
Address
6 Heddon Street, London, United Kingdom, W1B 4BT
Country
UK
Sector
Healthcare
Industry
Biotechnology
Currency
GBX
Website
https://genflowbio.com
Description
Genflow Biosciences plc, together with its subsidiaries, engages in the research and development of gene therapy targeting the upstream biology of aging in the United Kingdom and Belgium. The company operates as a pre-clinical biotechnology company that focuses on developing biological interventions aimed at tackling the effects of aging, slowing, and halting the aging process, as well as reducing the incidence of age-related diseases. Its lead drug candidate is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-1003, a topical delivery of SIRT6 to the fibroblasts in the skin; GF-1004, a non-human pipeline anti-aging for veterinary use; GF-1005, which addresses mitochondrial dysfunction observed in sarcopenia for muscle health and combat sarcopenia; and GF-1006, an ophthalmology mRNA cent SIRT6 for the treatment of cornea pathologies and glaucoma. The company has collaborative research agreements with Revatis SA and EXO Biologics for therapy medicinal products. Genflow Biosciences plc was founded in 2020 and is headquartered in London, the United Kingdom.
Last Close
18000
Volume
570267
Current Price
1.8285
Change
0
Last Updated
2025-12-30T10:57:51.452Z
Image
https://logo.clearbit.com/genflowbio.com
Ipo Date
-
Market Cap
8735798
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.922
Sentiment Sources
1
Current Quarter
2025-06-30
Revenue
122554
Cost Of Revenue
-
Gross Profit
122554
Operating Expenses
491363
Operating Income
-368809
Interest Expense
-
Pretax Income
-368809
Net Income
-368809
Eps
-0.0009597342096582317
Dividends Per Share
-
Shares Outstanding
493547942
Income Tax Expense
-
EBITDA
-368510
Operating Margin
-300.93591396445646
Total Other Income Expense Net
-
Cash
279445
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
466853
Property Plant Equipment
1528
Total Assets
468381
Payables
573297
Short Term Debt
-
Long Term Debt
-
Total Liabilities
771384
Equity
-303003
Bs_currency_symbol
GBP
Depreciation
299
Change In Working Capital
-41125
Cash From Operations
-418401
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
434349
Net Change In Cash
-
Cf_currency_symbol
-
PE
-
PB
-2318.9883737982796
ROE
121.71793678610443
ROA
-78.74123843623033
FCF
-418401
Fcf Percent
-3.414013414494835
Piotroski FScore
0
Health Score
30
Deep Value Investing Score
1
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
2.5
Net Net Investing Score
0.5
Quality Investing Score
3
Value Investing Score
3
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
122554
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
122554
Quarters > 0 > income Statement > operating Expenses
491363
Quarters > 0 > income Statement > operating Income
-368809
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-368809
Quarters > 0 > income Statement > net Income
-368809
Quarters > 0 > income Statement > eps
-0.0009597342096582317
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
384282436
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-368510
Quarters > 0 > income Statement > operating Margin
-300.93591396445646
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
279445
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
466853
Quarters > 0 > balance Sheet > property Plant Equipment
1528
Quarters > 0 > balance Sheet > total Assets
468381
Quarters > 0 > balance Sheet > payables
573297
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
771384
Quarters > 0 > balance Sheet > equity
-303003
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-368809
Quarters > 0 > cash Flow > depreciation
299
Quarters > 0 > cash Flow > change In Working Capital
-41125
Quarters > 0 > cash Flow > cash From Operations
-418401
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
434349
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.0009597342096582317
Quarters > 0 > ratios > PB
-2318.9883737982796
Quarters > 0 > ratios > ROE
121.71793678610443
Quarters > 0 > ratios > ROA
-78.74123843623033
Quarters > 0 > ratios > FCF
-418401
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-3.414013414494835
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
122554
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
122554
Quarters > 1 > income Statement > operating Expenses
491363
Quarters > 1 > income Statement > operating Income
-368809
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-368809
Quarters > 1 > income Statement > net Income
-368809
Quarters > 1 > income Statement > eps
-0.0009597342096582317
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
384282436
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-368510
Quarters > 1 > income Statement > operating Margin
-300.93591396445646
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
279445
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
466853
Quarters > 1 > balance Sheet > property Plant Equipment
1528
Quarters > 1 > balance Sheet > total Assets
468381
Quarters > 1 > balance Sheet > payables
573297
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
771384
Quarters > 1 > balance Sheet > equity
-303003
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-368809
Quarters > 1 > cash Flow > depreciation
299
Quarters > 1 > cash Flow > change In Working Capital
-41125
Quarters > 1 > cash Flow > cash From Operations
-418401
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
434349
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.0009597342096582317
Quarters > 1 > ratios > PB
-2318.9883737982796
Quarters > 1 > ratios > ROE
121.71793678610443
Quarters > 1 > ratios > ROA
-78.74123843623033
Quarters > 1 > ratios > FCF
-418401
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-3.414013414494835
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
-396055
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-396055
Quarters > 2 > income Statement > operating Expenses
-24803
Quarters > 2 > income Statement > operating Income
-371252
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-531488
Quarters > 2 > income Statement > net Income
-531488
Quarters > 2 > income Statement > eps
-0.001514925845313646
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
350834334
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-531201
Quarters > 2 > income Statement > operating Margin
93.7374859552335
Quarters > 2 > income Statement > total Other Income Expense Net
-160236
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
278682
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
36506
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
383841
Quarters > 2 > balance Sheet > property Plant Equipment
2067
Quarters > 2 > balance Sheet > total Assets
385908
Quarters > 2 > balance Sheet > payables
368897
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
788916
Quarters > 2 > balance Sheet > equity
-403008
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-531488
Quarters > 2 > cash Flow > depreciation
287
Quarters > 2 > cash Flow > change In Working Capital
47780
Quarters > 2 > cash Flow > cash From Operations
-441755
Quarters > 2 > cash Flow > capital Expenditures
372
Quarters > 2 > cash Flow > cash From Investing
372
Quarters > 2 > cash Flow > cash From Financing
-3482
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.001514925845313646
Quarters > 2 > ratios > PB
-1591.7812542654242
Quarters > 2 > ratios > ROE
131.88026044148006
Quarters > 2 > ratios > ROA
-137.72401712325217
Quarters > 2 > ratios > FCF
-442127
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
1.1163272777770765
Quarters > 2 > health Score
49
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
-97034
Quarters > 3 > income Statement > cost Of Revenue
621
Quarters > 3 > income Statement > gross Profit
-97655
Quarters > 3 > income Statement > operating Expenses
982461
Quarters > 3 > income Statement > operating Income
-983080
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-1007166
Quarters > 3 > income Statement > net Income
-1007166
Quarters > 3 > income Statement > eps
-0.0034432246589374605
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
292506618
Quarters > 3 > income Statement > income Tax Expense
-1
Quarters > 3 > income Statement > EBITDA
-982460
Quarters > 3 > income Statement > operating Margin
1013.1294185543211
Quarters > 3 > income Statement > total Other Income Expense Net
-24086
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
683974
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
384285
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1068259
Quarters > 3 > balance Sheet > property Plant Equipment
3394
Quarters > 3 > balance Sheet > total Assets
1071653
Quarters > 3 > balance Sheet > payables
254695
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
345738
Quarters > 3 > balance Sheet > equity
725915
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
-1007166
Quarters > 3 > cash Flow > depreciation
621
Quarters > 3 > cash Flow > change In Working Capital
222028
Quarters > 3 > cash Flow > cash From Operations
-811266
Quarters > 3 > cash Flow > capital Expenditures
2089
Quarters > 3 > cash Flow > cash From Investing
2089
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-823463
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.0034432246589374605
Quarters > 3 > ratios > PB
736.7919811727268
Quarters > 3 > ratios > ROE
-138.74434334598405
Quarters > 3 > ratios > ROA
-93.98247380448709
Quarters > 3 > ratios > FCF
-813355
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
8.382165014324876
Quarters > 3 > health Score
45
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
1204
Annuals > 0 > income Statement > gross Profit
-1204
Annuals > 0 > income Statement > operating Expenses
1906502
Annuals > 0 > income Statement > operating Income
-1266764
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-1587235
Annuals > 0 > income Statement > net Income
-1587235
Annuals > 0 > income Statement > eps
-0.004745664312934451
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
334460024
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-1586056
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-320471
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
278682
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
36506
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
383841
Annuals > 0 > balance Sheet > property Plant Equipment
2067
Annuals > 0 > balance Sheet > total Assets
385908
Annuals > 0 > balance Sheet > payables
368897
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
788916
Annuals > 0 > balance Sheet > equity
-403008
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-1587235
Annuals > 0 > cash Flow > depreciation
1179
Annuals > 0 > cash Flow > change In Working Capital
503783
Annuals > 0 > cash Flow > cash From Operations
-1082273
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
656635
Annuals > 0 > cash Flow > net Change In Cash
-405292
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.004745664312934451
Annuals > 0 > ratios > PB
-1468.9391835397807
Annuals > 0 > ratios > ROE
393.84702040654275
Annuals > 0 > ratios > ROA
-411.2988069695368
Annuals > 0 > ratios > FCF
-1082273
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
1034
Annuals > 1 > income Statement > gross Profit
-1034
Annuals > 1 > income Statement > operating Expenses
1797525
Annuals > 1 > income Statement > operating Income
-1798560
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-1628705
Annuals > 1 > income Statement > net Income
-1628705
Annuals > 1 > income Statement > eps
-0.005568096240475489
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
292506618
Annuals > 1 > income Statement > income Tax Expense
-4
Annuals > 1 > income Statement > EBITDA
-1797530
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
169855
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
683974
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
343244
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
1068259
Annuals > 1 > balance Sheet > property Plant Equipment
3394
Annuals > 1 > balance Sheet > total Assets
1071653
Annuals > 1 > balance Sheet > payables
254695
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
345738
Annuals > 1 > balance Sheet > equity
725915
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-1628705
Annuals > 1 > cash Flow > depreciation
1034
Annuals > 1 > cash Flow > change In Working Capital
-27786
Annuals > 1 > cash Flow > cash From Operations
-1655457
Annuals > 1 > cash Flow > capital Expenditures
2439
Annuals > 1 > cash Flow > cash From Investing
-2439
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
-1672251
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.005568096240475489
Annuals > 1 > ratios > PB
713.2194731614583
Annuals > 1 > ratios > ROE
-224.36580040362855
Annuals > 1 > ratios > ROA
-151.98063179032766
Annuals > 1 > ratios > FCF
-1657896
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
27
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
130
Annuals > 2 > income Statement > gross Profit
-130
Annuals > 2 > income Statement > operating Expenses
1334943
Annuals > 2 > income Statement > operating Income
-1334943
Annuals > 2 > income Statement > interest Expense
382
Annuals > 2 > income Statement > pretax Income
-1335325
Annuals > 2 > income Statement > net Income
-1335326
Annuals > 2 > income Statement > eps
-0.004565113805390892
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
292506618
Annuals > 2 > income Statement > income Tax Expense
1
Annuals > 2 > income Statement > EBITDA
-1334813
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-382
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
2356225
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
127471
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
2615110
Annuals > 2 > balance Sheet > property Plant Equipment
2351
Annuals > 2 > balance Sheet > total Assets
2617461
Annuals > 2 > balance Sheet > payables
83590
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
250988
Annuals > 2 > balance Sheet > equity
2366473
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-1335325
Annuals > 2 > cash Flow > depreciation
129
Annuals > 2 > cash Flow > change In Working Capital
-176778
Annuals > 2 > cash Flow > cash From Operations
-1368854
Annuals > 2 > cash Flow > capital Expenditures
2480
Annuals > 2 > cash Flow > cash From Investing
-2480
Annuals > 2 > cash Flow > cash From Financing
3499516
Annuals > 2 > cash Flow > net Change In Cash
2132221
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.004565113805390892
Annuals > 2 > ratios > PB
218.77989474631656
Annuals > 2 > ratios > ROE
-56.426842816292435
Annuals > 2 > ratios > ROA
-51.01608008677111
Annuals > 2 > ratios > FCF
-1371334
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
27
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
938096
Annuals > 3 > income Statement > operating Income
-988096
Annuals > 3 > income Statement > interest Expense
99
Annuals > 3 > income Statement > pretax Income
-988195
Annuals > 3 > income Statement > net Income
-988294
Annuals > 3 > income Statement > eps
-0.003378706460583398
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
292506618
Annuals > 3 > income Statement > income Tax Expense
99
Annuals > 3 > income Statement > EBITDA
-988096
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-99
Annuals > 3 > income Statement > currency_symbol
GBX
Annuals > 3 > balance Sheet > cash
224004
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
52547
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
276551
Annuals > 3 > balance Sheet > property Plant Equipment
0
Annuals > 3 > balance Sheet > total Assets
276551
Annuals > 3 > balance Sheet > payables
37686
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
221427
Annuals > 3 > balance Sheet > equity
55124
Annuals > 3 > balance Sheet > currency_symbol
GBX
Annuals > 3 > cash Flow > net Income
-988195
Annuals > 3 > cash Flow > depreciation
236558
Annuals > 3 > cash Flow > change In Working Capital
171759
Annuals > 3 > cash Flow > cash From Operations
-747377
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
198502
Annuals > 3 > cash Flow > cash From Financing
783711
Annuals > 3 > cash Flow > net Change In Cash
234836
Annuals > 3 > cash Flow > currency_symbol
GBX
Annuals > 3 > ratios > PE
-0.003378706460583398
Annuals > 3 > ratios > PB
9392.219611421522
Annuals > 3 > ratios > ROE
-1792.8561062332196
Annuals > 3 > ratios > ROA
-357.36410282371065
Annuals > 3 > ratios > FCF
-747377
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
8
Valuation > metrics > PE
-0.0009597342096582317
Valuation > metrics > PB
-2318.9883737982796
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
121.71793678610443
Profitability > metrics > ROA
-78.99895684508829
Profitability > metrics > Net Margin
-3.0093591396445647
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-1233.4749163879599
Risk > final Score
-4904
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.8143300941745727
Liquidity > metrics > Quick Ratio
0.8143300941745727
Liquidity > final Score
51
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
20
Prev Profitabilities > 0
40
Prev Profitabilities > 1
70
Prev Profitabilities > 2
30
Prev Risks > 0
-4904
Prev Risks > 1
-5144
Prev Risks > 2
-99
Prev Liquidities > 0
51
Prev Liquidities > 1
76
Prev Liquidities > 2
100
Updated At
2026-01-23T19:57:41.101Z
Earnings History > 0 > period
2025-03-31
Earnings History > 0 > report Date
2025-04-30
Earnings History > 0 > date
2025-03-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-06-30
Earnings History > 1 > report Date
2024-09-30
Earnings History > 1 > date
2024-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2023-03-31
Earnings History > 2 > report Date
2023-04-24
Earnings History > 2 > date
2023-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
GBP
Earnings History > 2 > eps Actual
0
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-06-30
Earnings History > 3 > report Date
2022-09-30
Earnings History > 3 > date
2022-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
GBP
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-03-31
Earnings History > 4 > report Date
2022-04-25
Earnings History > 4 > date
2022-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
GBP
Earnings History > 4 > eps Actual
-0.02
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.02
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2021-12-31
Earnings History > 5 > report Date
2022-01-17
Earnings History > 5 > date
2021-12-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
GBP
Earnings History > 5 > eps Actual
0
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Genflow Biosciences plc, together with its subsidiaries, engages in the research and development of gene therapy targeting the upstream biology of aging in the United Kingdom and Belgium. The company operates as a pre-clinical biotechnology company that focuses on developing biological interventions aimed at tackling the effects of aging, slowing, and halting the aging process, as well as reducing the incidence of age-related diseases. Its lead drug candidate is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-1003, a topical delivery of SIRT6 to the fibroblasts in the skin; GF-1004, a non-human pipeline anti-aging for veterinary use; GF-1005, which addresses mitochondrial dysfunction observed in sarcopenia for muscle health and combat sarcopenia; and GF-1006, an ophthalmology mRNA cent SIRT6 for the treatment of cornea pathologies and glaucoma. The company has collaborative research agreements with Revatis SA and EXO Biologics for therapy medicinal products. Genflow Biosciences plc was founded in 2020 and is headquartered in London, the United Kingdom.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AGenflow shares jump as biotech appoints new chairman Proactive financial news
Read more →Genflow shares jump as biotech appoints new chairman Proactive financial news
Read more →Showing 2 of 9
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Genflow Biosciences plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-03-31
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.